How a specific receptor affects the function of regulatory T cells in tissue repair
Control of Regulatory T Cell Function by Toll-Like Receptor 7
This study is looking at how a specific part of the immune system, called TLR7, helps certain immune cells called regulatory T cells do their job better in healing damaged tissues, which could lead to new ways to help people recover from injuries or illnesses.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Berkeley NIH-funded |
| Lab location | 1 site (Berkeley, United States) |
| Project ID | NIH-10876458 on NIH RePORTER |
What this research studies
This research investigates the role of Toll-like receptor 7 (TLR7) in regulating the function of regulatory T cells (Tregs), which are essential for maintaining immune balance and promoting tissue repair. The study aims to understand how TLR7 signaling influences Tregs to produce factors that aid in healing damaged tissues. By using specialized mouse models, researchers will explore the mechanisms by which TLR7 helps Tregs respond to signals from both pathogens and damaged cells. This could lead to new insights into how Tregs can be harnessed for therapeutic purposes in tissue repair.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that involve tissue damage or require enhanced healing processes.
Not a fit: Patients with stable, non-damaging conditions or those not requiring tissue repair may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could enhance our understanding of immune responses and lead to improved therapies for tissue repair and regeneration.
How similar studies have performed: Previous research has shown promising results in understanding Treg functions, but the specific role of TLR7 in tissue repair is a novel area of investigation.
Where this research is happening
Berkeley, United States
- University of California Berkeley — Berkeley, United States (Active)
Researchers
- Principal investigator: Barton, Gregory M — University of California Berkeley
- Study coordinator: Barton, Gregory M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.